226-240 of 811
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Deep Breaths: Updates from CHESTUnderstanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Project Oncology®Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- advertisement
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Living RheumRecognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Oncology and HematologySunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
First Results From Cohort 4 of the SunRISe-1 Trial
Oncology and HematologyFirst Results From Cohort 4 of the SunRISe-1 Trial
- advertisement
Trial in Progress: Phase 3 MoonRISe-3 Study
Oncology and HematologyTrial in Progress: Phase 3 MoonRISe-3 Study
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's RoundtableProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
